Anticonvulsant treatment of nerve agent seizures: Anticholinergics versus diazepam in soman-intoxicated guinea pigs

Epilepsy Research

Volumn 38, Issue 1, 1999, Pages 1-14

  McDonough Jr , John H ^a   Zoeffel, L Dean ^a   McMonagle, Joseph ^a   Copeland, Tracy L ^a   Smith, C Dahlem ^a   Shih, Tsung Ming ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Anticholinergic; Anticonvulsant; Diazepam; EEG; Guinea pig; Nerve agent; Neuropathology; Seizure; Soman; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; ATROPINE; AZAPROPHEN; BENACTYZINE; BIPERIDEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; PRALIDOXIME; PROCYCLIDINE; PYRIDOSTIGMINE; SCOPOLAMINE; SOMAN; TRIHEXYPHENIDYL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; AVOIDANCE BEHAVIOR; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; ELECTROENCEPHALOGRAM; GUINEA PIG; INTOXICATION; LETHALITY; MALE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SURVIVAL;

ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; BODY WEIGHT; CHEMICAL WARFARE AGENTS; CHOLINERGIC ANTAGONISTS; CONVULSANTS; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; GUINEA PIGS; MALE; NERVOUS SYSTEM; SOMAN; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033374581     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(99)00060-1     Document Type: Article

References (45)

1. Anderson D.R., Gennings C., Carter W.H., Harris L.W., Lennox W.J., Bowersox S.L., Solana R.P. Efficacy comparison of scopolamine and diazepam against soman-induced debilitation in guinea pigs. Fundam. Appl. Toxicol. 22:1994;588-593.
2. Anderson D.R., Harris L.W., Bowersox S.L., Lennox W.J., Anders J.C. Efficacy of injectable anticholinergic drugs against soman-induced convulsive/subconvulsive activity. Drug Chem. Toxicol. 17:1994;139-148.
3. Anderson D.R., Harris L.W., Chang F.T., Baze W.B., Capacio B.R., Byers S.L., Lennox W.J. Antagonism of soman-induced convulsions by midazolam, diazepam and scopolamine. Drug Chem. Toxicol. 20:1997;115-131.
4. Baze W.B. Soman-induced morphological changes: an overview in the non-human primate. J. Appl. Toxicol. 13:1993;173-177.
5. Bliss C.I. The statistics of bioassay with special reference to the vitamins. Vitamin Methods. II:1952;Academic Press, New York.
6. Capacio B.R., Shih T.-M. Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia. 32:1991;604-615.
7. Carpentier P., Delamanche I.S., Le Bert M., Blanchet G., Bouchaud C. Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology. 11:1990;493-508.
8. Castro C.A., Larsen T., Finger A.V., Solana R.P., McMaster S.B. Behavioral efficacy of diazepam against nerve agent exposure in rhesus monkeys. Pharmacol. Biochem. Behav. 41:1991;159-164.
9. Clement J.G., Broxup B. Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats. Neurotoxicology. 14:1993;485-504.
10. Dixon W.J., Massey F.J. Sensitivity experiments. Introduction to Statistical Analysis. fourth ed. 1981;426-441 McGraw-Hill, New York.
11. Dunn M.A., Sidell F.R. Progress in medical defense against nerve agents. JAMA. 262:1989;649-652.
12. Fujikawa D.G. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia. 36:1995;186-195.
13. Green D.M., Muir A.W., Stratton J.A., Inch T.D. Dual mechanisms of antidotal action of atropine-like drugs in poisoning by organophosphorus anticholinesterases. J. Pharm. Pharmacol. 29:1977;62-64.
14. Harris L.W., Gennings C., Carter W.H., Anderson D.R., Lennox W.J., Bowersox S.L., Solana R.P. Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs. Drug Chem. Toxicol. 17:1994;35-50.
15. Hayward I.J., Wall H.G., Jaax N.K., Wade J.V., Marlow D.D., Nold J.B. Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J. Neurol. Sci. 98:1990;99-106.
16. Lallement G., Pernot-Marino I., Baubichon D., Burckhart M.-F., Carpentier P., Blanchet G. Modulation of soman-induced neuropathology with an anticonvulsant regimen. NeuroReport. 5:1994;2265-2268.
17. Lallement G., Clarencon D., Brochier G., Baubichon D., Galonnier M., Blanchet G., Mestries J.-C. Efficacy of atropine/pralidoxime/diazepam or atropine/HI-6/prodiazepam in primates intoxicated by soman. Pharmacol. Biochem. Behav. 56:1997;325-332.
18. Lallement G., Dorandeu F., Filliat P., Carpentier P., Baille V., Blanchet G. Medical management of organophosphate-induced seizures. J. Physiol. Paris. 92:1998;369-373.
19. Lemercier G., Carpentier P., Sentenac-Roumanou H., Moralis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. 61:1983;123-129.
20. Lennox W.J., Harris L.W., Talbot B.G., Anderson D.R. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sci. 37:1985;793-798.
21. Lipp J.A. Cerebral electrical activity following soman administration. Arch. Int. Pharmacodyn. 175:1968;161-169.
22. Martin L.J., Doebler J.A., Shih T.-M., Anthony A. Protective effect of diazepam pretreatment on soman-induced brain lesion formation. Brain Res. 325:1985;287-289.
23. McDonough J.H., Shih T.-M. Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 17:1993;203-215.
24. McDonough J.H., Shih T.-M. A study of the N-methyl-D-aspartate antagonist properties of anticholinergic drugs. Pharmacol. Biochem. Behav. 51:1995;249-253.
25. McDonough J.H., Shih T.-M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 21:1997;559-579.
26. McDonough J.H., Jaax N.K., Crowley R.A., Mays M.Z., Modrow H.E. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 13:1989;256-276.
27. McDonough J.H., Dochterman L.W., Smith C.D., Shih T.-M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology. 16:1995;123-132.
28. Moore D.H., Clifford C.B., Crawford I.T., Cole G.M., Baggett J.M. Review of nerve agent inhibitors and reactivators of acetylcholinesterase. Quinn D.M., Balasubramanian A.S., Doctor B.P., Taylor P. Enzymes of the Cholinesterase Family. 1995;297-304 Plenum Press, New York.
29. Morita M., Yanagisawa N., Nakajima T., Shimizu M., Hirabayashi H., Okudera H., Nohara M., Midorikawa Y., Mimura S. Sarin poisoning in Matusmoto, Japan. Lancet. 346:1995;290-293.
30. Morrisett R.A., Jope R.S., Snead O.C. Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium pretreated rats. Exp. Neurol. 97:1987;193-200.
31. Nozaki H., Aikawa N., Fujishima S., Suzuki M., Shinozawa Y., Hori S., Nogawa S. A case of VX poisoning and the difference from sarin. Lancet. 346:1995;698-699.
32. Ohbu S., Yamashina A., Takasu N., Yamaguchi T., Murai T., Nakano K., Matsui Y., Mikami R., Sakurai K., Hinohara S. Sarin poisoning on Tokyo subway. South. Med. J. 90:1997;587-593.
33. Olney J.W., Price M.T., Labruyere J., Salles K.S., Frierdrich G., Mueller M., Silverman E. Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur. J. Pharmacol. 142:1987;319-320.
34. Okumura T., Takasu N., Ishimatsu S., Miyanoki S., Mitsuhashi A., Kumada K., Tanaka K., Hinohara S. Report on 640 victims of the Tokyo subway sarin attack. Ann. Emerg. Med. 28:1996;129-135.
35. Philippens I.H.C.H.M., Melchers B.P.C., DeGroot D.M.G., Wolthius O.L. Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats. Pharmacol. Biochem. Behav. 42:1992;711-719.
36. Shih T.-M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 7:1990;105-116.
37. Shih T.-M., Koviak T.A., Capacio B.R. Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci. Biobehav. Rev. 15:1991;349-362.
38. Shih T.-M., McDonough J.H., Koplovitz I. Evaluation of anticonvulsant drugs for soman-induced seizure activity. J. Am. Coll. Toxicol. 15(Suppl. 2):1997;S43-S60.
39. Sidell F.R. Clinical considerations in nerve agent intoxication. Somani S. Chemical Warfare Agents. 1992;155-194 Academic Press, New York.
40. Sidell F.R. Clinical effects of organophosphorus cholinesterase inhibitors. J. Appl. Toxicol. 14:1994;111-113.
41. Sket D. Efficacy of antidotes against soman poisoning in female physostigmine-protected rats. Pharmacol. Toxicol. 72:1993;25-30.
42. Sparenborg S., Brennecke L.H., Beers E.T. Pharmacological dissociation of the motor and electrical aspects of convulsive status epilepticus induced by the cholinesterase inhibitor soman. Epilepsy Res. 14:1993;95-103.
43. Walton N.Y., Treiman D.M. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp. Neurol. 101:1988;267-275.
44. Walton N.Y., Treiman D.M. Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam. Brain Res. 553:1991;97-104.
45. Winer B.J. Statistical Principles in Experimental Design. 1971;McGraw-Hill, New York.